Short Interest in NeueHealth, Inc. (NYSE:NEUE) Drops By 54.0%

NeueHealth, Inc. (NYSE:NEUE - Get Free Report) saw a significant decrease in short interest in January. As of January 15th, there was short interest totalling 9,700 shares, a decrease of 54.0% from the December 31st total of 21,100 shares. Approximately 0.8% of the shares of the stock are sold short. Based on an average daily volume of 34,400 shares, the days-to-cover ratio is currently 0.3 days.

Insider Activity at NeueHealth

In related news, CEO George Lawrence Mikan III sold 31,798 shares of the stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $233,079.34. Following the sale, the chief executive officer now directly owns 146,539 shares of the company's stock, valued at $1,074,130.87. This represents a 17.83 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Jay Matushak sold 4,970 shares of the firm's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the sale, the chief financial officer now directly owns 17,747 shares of the company's stock, valued at approximately $130,085.51. The trade was a 21.88 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 58,658 shares of company stock valued at $377,034 over the last 90 days. 64.30% of the stock is owned by corporate insiders.

Institutional Investors Weigh In On NeueHealth

An institutional investor recently bought a new position in NeueHealth stock. Partners Group Holding AG purchased a new stake in shares of NeueHealth, Inc. (NYSE:NEUE - Free Report) during the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 88,645 shares of the company's stock, valued at approximately $463,000. Partners Group Holding AG owned approximately 1.07% of NeueHealth at the end of the most recent quarter. 63.88% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada decreased their price objective on shares of NeueHealth from $8.00 to $7.00 and set a "sector perform" rating for the company in a report on Monday, December 9th.

NeueHealth Stock Up 0.3 %

NYSE:NEUE traded up $0.03 during midday trading on Monday, hitting $7.34. The stock had a trading volume of 45,477 shares, compared to its average volume of 35,523. The stock has a 50-day moving average of $6.32 and a 200 day moving average of $5.65. The company has a market capitalization of $60.73 million, a price-to-earnings ratio of -0.14 and a beta of 0.58. NeueHealth has a one year low of $3.79 and a one year high of $11.35.

NeueHealth (NYSE:NEUE - Get Free Report) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($6.78) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($2.72) by ($4.06). The firm had revenue of $232.93 million for the quarter, compared to the consensus estimate of $230.21 million. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. During the same period in the previous year, the company posted ($8.31) EPS. On average, sell-side analysts anticipate that NeueHealth will post -9.13 earnings per share for the current fiscal year.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.